Subscribe To

Price Alert Latest News Economic Calendar News

HSDT / Helius Medical Technologies to Present at LD Micro Invitational XIII 2023

Newtown, Pennsylvania--(Newsfile Corp. - May 25, 2023) - Helius Medical Technologies, Inc. (NASDAQ: HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present at LD Micro Invitational XIII 2023, at the Luxe Sunset Boulevard Hotel, California, as follows: Date: Wednesday, June 7, 2023Time: 4:00 PM PTWebcast: Click here Investors and attendees who would like to schedule a 1-on-1 meeting with Helius management are asked to contact LD Micro. About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain's ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic diseases. Read More

Demo Live Account See Partner Details

Content Topics

Helius

Medical

Technologies

Present

Micro

Invitational

Xiii

Stock

HSDT

Posted: May 25 2023, 07:05

Author Name: Newsfile Corp

HSDT News

By GlobeNewsWire
November 2, 2023

Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024

-- Expects to report Q3 revenues in range of $140 - $150 thousand, reflecting the expected decrease in U.S. sales with the conclusion of the Patient T

By GlobeNewsWire
September 13, 2023

Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference

-- Presentation to educate on Portable Neuromodulation Stimulator (PoNS®) Therapy, highlighting the differentiation from other neuromodulation techno

By InvestorPlace
September 5, 2023

Why Is Helius Medical Technologies (HSDT) Stock Up 47% Today?

Helius Medical Technologies (NASDAQ: HSDT ) stock is rising higher on Tuesday as investors react to the neurotechnology company regaining listing com

By Seeking Alpha
August 10, 2023

Helius Medical Technologies, Inc. (HSDT) Q2 2023 Earnings Call Transcript

Helius Medical Technologies, Inc. (NASDAQ:HSDT ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Michelle Bilski - In

By Zacks Investment Research
August 10, 2023

Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Tops Revenue Estimates

Helius Medical Technologies, Inc. (HSDT) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.11. Thi

By GlobeNewsWire
June 14, 2023

Helius Medical Technologies to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest

NEWTOWN, Pa., June 14, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech compa

By Newsfile Corp
May 25, 2023

Helius Medical Technologies to Present at LD Micro Invitational XIII 2023

Newtown, Pennsylvania--(Newsfile Corp. - May 25, 2023) - Helius Medical Technologies, Inc. (NASDAQ: HSDT) ("Helius" or the "Company"), a neurotech com

By Seeking Alpha
March 10, 2023

Helius Medical Technologies, Inc. (HSDT) Q4 2022 Earnings Call Transcript

Helius Medical Technologies, Inc. (NASDAQ:HSDT ) Q4 2022 Earnings Conference Call March 9, 2023 4:30 PM ET Company Participants Michelle Bilski - In-S

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.